Ozempic vs Zepbound
A proven diabetes drug meets a next-generation weight loss injection. Different mechanisms, one important choice.
15%
Avg weight loss Ozempic
21%
Avg weight loss Zepbound
$935/mo
Ozempic retail (no insurance)
$99
Ozempic via telehealth
What are they?
Two weekly injections with different active molecules — Ozempic uses semaglutide, Zepbound uses tirzepatide — and they’re approved for very different conditions.
Ozempic is FDA-approved for type 2 diabetes, not for weight loss. Wegovy is the FDA-approved semaglutide formulation for chronic weight management.
Ozempic
Type 2 DiabetesFDA-approved to improve blood sugar in adults with type 2 diabetes. Frequently prescribed off-label for weight loss due to its semaglutide formulation.
Maker
Novo Nordisk
Approved
2017
Format
Weekly injection
Max dose
2.0 mg
Zepbound
Weight ManagementFDA-approved for chronic weight management in adults with obesity (BMI 30+) or overweight (BMI 27+) with at least one weight-related condition. Uses the same dual GIP/GLP-1 mechanism as Mounjaro at equivalent doses.
Maker
Eli Lilly
Approved
2024
Format
Weekly injection
Max dose
15 mg
Quick comparison
How they stack up on the metrics that matter most.
| Feature | Ozempic | Zepbound |
|---|---|---|
| Active ingredient | Semaglutide | Tirzepatide |
| FDA approved for | Type 2 diabetes | Weight Management |
| Max dose | 2.0 mg | 15 mg |
| Avg weight loss | 13.7% | 20.2% |
| Administration | Weekly injection | Weekly injection |
| Insurance | Broader | Limited |
| Retail price/mo | $935/mo | $1,059/mo |
| Telehealth price | From $99/mo | From $149/mo |
Ozempic
Semaglutide
Zepbound
Tirzepatide
Ozempic
Type 2 diabetes
Zepbound
Weight Management
Ozempic
2.0 mg
Zepbound
15 mg
Ozempic
13.7%
Zepbound
20.2%
Ozempic
Weekly injection
Zepbound
Weekly injection
Ozempic
Broader
Zepbound
Limited
Ozempic
$935/mo
Zepbound
$1,059/mo
Ozempic
From $99/mo
Zepbound
From $149/mo
More energy,
less weight
How you ramp up
Both medications use a gradual dose escalation to minimize side effects.
Ozempic
- 1
0.25 mg
Weeks 1–4
- 2
0.5 mg
Weeks 5–8
- 3
1.0 mg
Weeks 9+
(Maintenance)
- 4
2.0 mg
Optional max dose
Zepbound
- 1
2.5 mg
Weeks 1–4
- 2
5 mg
Weeks 5–8
- 3
7.5 mg
Weeks 9–12
- 4
10 mg
Weeks 13–16
- 5
12.5 mg
Weeks 17–20
- 6
15 mg
Weeks 21+
(Maintenance)
What you’ll pay
Real pricing — no misleading teaser rates or hidden fees.
Ozempic
- Retail (no insurance)
- $935/mo
- With insurance
- $25–$150/mo
- Telehealth (compounded)
- From $99/mo
- Manufacturer savings
- Available
Special offer
Save up to 30% EVERY month!
Zepbound
- Retail (no insurance)
- $1,059/mo
- With insurance
- $25–$200/mo
- Telehealth (compounded)
- From $149/mo
- Manufacturer savings
- Available
Special offer
Save up to 30% EVERY month!
Some providers pay BestGLP1 a referral fee when you sign up. We disclose this because the FTC requires it. Our rankings are editorial.
Start your weight‑loss
journey today
Weight loss compared
Clinical trial data showing average body weight reduction over 72 weeks.
Ozempic (2.0 mg)
Zepbound (15 mg)
Data based on the SURMOUNT-5 Phase 3b study, released May 2025 — a head-to-head, 72-week study of Semaglutide vs Tirzepatide.
What to expect
How they stack up on the metrics that matter most.
| Side Effect | Ozempic | Zepbound |
|---|---|---|
| Nausea | 20% | 25% |
| Diarrhea | 9% | 19% |
| Vomiting | 9% | 8% |
| Constipation | 3.1% | 17% |
| Headache | 1.6% | 4% |
| Fatigue | 2.5% | 5% |
Ozempic
20%
Zepbound
25%
Ozempic
9%
Zepbound
19%
Ozempic
9%
Zepbound
8%
Ozempic
3.1%
Zepbound
17%
Ozempic
1.6%
Zepbound
4%
Ozempic
2.5%
Zepbound
5%
Side effects are generally most pronounced during the first 4–8 weeks and tend to subside. Always consult your healthcare provider.
The bottom line
Two effective weekly injections with different mechanisms and approved uses. Here’s how to think about it.
Choose based on your goal
- Choose Ozempic if you have type 2 diabetes, want the broadest insurance coverage, or prefer the lowest telehealth entry price starting from $99/month.
- Choose Zepbound if weight loss is your primary goal and you want Zepbound (FDA-approved for chronic weight management) with dual GLP-1/GIP action and higher average outcomes.
Some providers pay BestGLP1 a referral fee when you sign up. We disclose this because the FTC requires it. Our rankings are editorial.
What you
need to know
Yes — many patients switch to Zepbound for stronger weight-loss results. Because they target different receptor pathways, your provider will typically restart you at the lowest Zepbound dose and titrate up over several months to manage tolerability.
Zepbound’s active ingredient (tirzepatide) targets two receptors — GIP and GLP-1 — while Ozempic’s semaglutide targets only GLP-1. Activating both pathways simultaneously appears to produce stronger appetite suppression and metabolic effects, which translates to higher average weight loss in head-to-head trials.
Trial data shows tirzepatide has somewhat higher rates of GI side effects (nausea, diarrhea, vomiting), particularly during dose escalation. Most subside after the first 4–8 weeks and respond well to gradual titration. Your provider can help you manage symptoms as you ramp up.
Yes. Both Ozempic and Zepbound require a prescription from a licensed healthcare provider. A consultation is required to assess whether treatment is appropriate for you.
BestGLP1 publishes these guides for informational and comparison purposes only. The information on this site is not medical advice, diagnosis, or treatment, and is not a substitute for guidance from a licensed healthcare professional. GLP-1 medications must be prescribed and monitored by a qualified provider; consult your provider to determine whether treatment is appropriate for your individual circumstances. Prices, side-effect rates, and clinical figures shown here are general references drawn from manufacturer labelling and published trials, and may not reflect your specific situation.
Find the right
GLP-1 for you
Compare side by side. No signup required.
What's your
target weight?
Let's find your perfect program
Some providers pay BestGLP1 a referral fee when you sign up. We disclose this because the FTC requires it. Our rankings are editorial.